Cancer Research Investments in Wisconsin: Strengthening the Economy and Saving Lives
July 13, 2011
August 11, 2011
Froedtert & The Medical College of Wisconsin Clinical Cancer Center
Milwaukee, WI
51st Annual Pharmaceutical Analysis Conference
July 13, 2011
August 1, 2011
Devil’s Head Resort and Conference Center
Merrimac, WI
July 13, 2011
Center for Advanced Technology and Innovation
Medical College of Wisconsin
Milwaukee County Research Park
Office of Governor Scott Walker
University of Wisconsin Biotechnology Center
Wisconsin Biotechnology and Medical Device Association
Wisconsin Department of Health Services
Wisconsin Medical Society
Wisconsin State Assembly
Wisconsin State Legislature
Wisconsin State Senate
BioForward Legislative Update Letter
July 13, 2011
The 2011-2012 legislative session brings an entirely new state legislature and a new Administration to Wisconsin. BioForward will be working on a variety of state issues this session, including a bioscience jobs initiative that is aimed at increasing investment in bioscience companies in Wisconsin and carefully monitoring the move toward restructuring the Department of Commerce to ensure that, as a part of any restructure, Act 255 and other critical programs to our members are protected and preserved.
Biotech Leaders’ Thoughts on Wisconsin’s Bioscience Industry
July 13, 2011
The Wisconsin Biotechnology and Medical Device Association offers video comments from biotech leaders who comment on the bioscience industry in the state.
Contribution of Biosciend Industry to the Wisconsin Economy
July 13, 2011
BioForward is pleased to share with you “The Contribution of the Bioscience Industry to the Wisconsin Economy,” a comprehensive analysis of the significant economic impact the bioscience industry has on Wisconsin. Indeed, the report shows that the bioscience industry is paying high wages, creating jobs and putting Wisconsin in a stronger position to transform its economic landscape in ways some previously thought unimaginable.
Wisconsin Bioscience Fact Sheet
July 13, 2011
Wisconsin can and should properly leverage the substantial economic advantages it has with this dynamic industry. The study finds credible evidence of the growing impact of bioscience throughout the state in the health, energy and agriculture sectors.
Getting it right on biosimilars and patient safety
July 11, 2011
By John Horton, President of LegitScript
Oregon Statesman Journal
In just the first three days of summer, at least six unrelated pharmaceutical manufacturers you’ve probably never heard of — companies with names like Xcellerex, Avesthagen, NeuClone and Lupin — were the subject of various press releases. The content varied, but all of the news involved the companies’ plans to refocus their business strategies on a promising new area of medicine: biologics. Read more.
Getting it right on biosimilars and patient safety
July 11, 2011
By John Horton, President of LegitScript
Oregon Statesman Journal
In just the first three days of summer, at least six unrelated pharmaceutical manufacturers you’ve probably never heard of — companies with names like Xcellerex, Avesthagen, NeuClone and Lupin — were the subject of various press releases. The content varied, but all of the news involved the companies’ plans to refocus their business strategies on a promising new area of medicine: biologics. Read more.
Patient Safety Depends on Prevention
June 29, 2011
By Andrew R. Spiegel
CEO, Colon Cancer Alliance
MedCity News
Prevention is a key message of the Colon Cancer Alliance. Over 80% of all cases of colorectal cancer can be prevented with recommended screenings. Despite its high incidence, colorectal cancer is one of the most detectable and, if found early enough, most treatable forms of cancer. With the widespread adoption of common screening practices, as many as 30,000 lives could be saved each year. Read More.
